Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 EUR | -0.78% | -0.78% | +9.91% |
13/06 | Mib down; Fed indicates only one cut for 2024 | AN |
12/06 | Mib closes sharply higher; focus on Fed | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 471.5 | 433.4 | 491.1 | 327.4 | 411 | 455 | - | - |
Enterprise Value (EV) 1 | 566.2 | 531.1 | 633.5 | 472.4 | 616.7 | 633 | 595 | 553 |
P/E ratio | 36 x | 37.9 x | 26.2 x | 15.3 x | 25.8 x | 17.5 x | 16.6 x | 15.2 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.4 x | 2.06 x | 1.73 x | 1.01 x | 1.11 x | 0.98 x | 0.96 x | 0.94 x |
EV / Revenue | 2.88 x | 2.52 x | 2.23 x | 1.46 x | 1.67 x | 1.37 x | 1.26 x | 1.15 x |
EV / EBITDA | 14.8 x | 15.6 x | 11.9 x | 8.06 x | 9.19 x | 7.82 x | 7.17 x | 6.43 x |
EV / FCF | -4.72 x | 123 x | 54.4 x | 16.3 x | - | 23.3 x | 15.7 x | 13.6 x |
FCF Yield | -21.2% | 0.81% | 1.84% | 6.12% | - | 4.3% | 6.39% | 7.34% |
Price to Book | 3.33 x | 2.34 x | 1.88 x | 1.17 x | 1.37 x | - | - | - |
Nbr of stocks (in thousands) | 81,859 | 81,773 | 89,298 | 88,966 | 88,578 | 88,529 | - | - |
Reference price 2 | 5.760 | 5.300 | 5.500 | 3.680 | 4.640 | 5.140 | 5.140 | 5.140 |
Announcement Date | 23/03/20 | 16/03/21 | 16/03/22 | 16/03/23 | 14/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 196.5 | 210.8 | 283.7 | 322.6 | 368.7 | 463 | 472 | 482 |
EBITDA 1 | 38.2 | 34 | 53.1 | 58.6 | 67.1 | 81 | 83 | 86 |
EBIT 1 | 24 | 15.49 | 28.23 | 31.66 | 39.23 | 49 | 50 | 53 |
Operating Margin | 12.21% | 7.35% | 9.95% | 9.82% | 10.64% | 10.58% | 10.59% | 11% |
Earnings before Tax (EBT) 1 | 18.66 | 13.02 | 23.99 | 27.37 | 28.93 | 36 | 38 | 41 |
Net income 1 | 13.14 | 11.78 | 18.83 | 21.43 | 20.8 | 26 | 28 | 30 |
Net margin | 6.69% | 5.59% | 6.64% | 6.64% | 5.64% | 5.62% | 5.93% | 6.22% |
EPS 2 | 0.1600 | 0.1400 | 0.2100 | 0.2400 | 0.1800 | 0.2940 | 0.3100 | 0.3380 |
Free Cash Flow 1 | -120 | 4.315 | 11.65 | 28.9 | - | 27.2 | 38 | 40.6 |
FCF margin | -61.07% | 2.05% | 4.11% | 8.96% | - | 5.87% | 8.05% | 8.42% |
FCF Conversion (EBITDA) | - | 12.69% | 21.93% | 49.32% | - | 33.58% | 45.78% | 47.21% |
FCF Conversion (Net income) | - | 36.63% | 61.83% | 134.89% | - | 104.62% | 135.71% | 135.33% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 23/03/20 | 16/03/21 | 16/03/22 | 16/03/23 | 14/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 89.9 | 133.5 | - | 80.41 | 85.88 | 166.3 | 70.28 | 86 | 92.28 | 94.38 | 186.7 | 76.47 | 105.6 | 126.1 |
EBITDA | 8.747 | 24.74 | - | 14.33 | 16.84 | 31.17 | 11.15 | 16.28 | 18.76 | 19.49 | 38.25 | 12.72 | 16.09 | - |
EBIT | 3.272 | - | - | 7.845 | 11.86 | 19.71 | 5.553 | 6.717 | 13.96 | 12.04 | 26.01 | 6.129 | 7.092 | - |
Operating Margin | 3.64% | - | - | 9.76% | 13.82% | 11.85% | 7.9% | 7.81% | 15.13% | 12.76% | 13.93% | 8.02% | 6.72% | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income 1 | 1.249 | 9.769 | 5.773 | - | - | - | - | - | - | - | - | - | - | 10.06 |
Net margin | 1.39% | 7.32% | - | - | - | - | - | - | - | - | - | - | - | 7.97% |
EPS | 0.0200 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 23/09/20 | 13/09/21 | 16/03/22 | 13/05/22 | 12/09/22 | 12/09/22 | 14/11/22 | 16/03/23 | 15/05/23 | 12/09/23 | 12/09/23 | 14/11/23 | 14/03/24 | 15/05/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 94.7 | 97.7 | 142 | 145 | 206 | 178 | 140 | 98 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.478 x | 2.873 x | 2.681 x | 2.475 x | 3.066 x | 2.198 x | 1.687 x | 1.14 x |
Free Cash Flow 1 | -120 | 4.32 | 11.6 | 28.9 | - | 27.2 | 38 | 40.6 |
ROE (net income / shareholders' equity) | 6.96% | 5.96% | 8.13% | 7.94% | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | 1.730 | 2.260 | 2.920 | 3.140 | 3.380 | - | - | - |
Cash Flow per Share | - | - | 0.4100 | 0.4900 | - | - | - | - |
Capex 1 | 8.81 | - | 24.7 | 15 | - | 18.5 | 18.9 | 20.8 |
Capex / Sales | 4.48% | - | 8.7% | 4.64% | - | 4% | 4% | 4.32% |
Announcement Date | 23/03/20 | 16/03/21 | 16/03/22 | 16/03/23 | 14/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.91% | 49Cr | |
-33.75% | 1.34TCr | |
+4.48% | 1.17TCr | |
-3.60% | 1.17TCr | |
+8.44% | 1.07TCr | |
+28.75% | 864.55Cr | |
-9.79% | 717.02Cr | |
+9.16% | 682.32Cr | |
+8.41% | 646.12Cr | |
0.00% | 499.47Cr |
- Stock Market
- Equities
- GHC Stock
- Financials Garofalo Health Care S.p.A.